Search by Drug Name or NDC

    NDC 50242-0923-01 Hemlibra 150 mg/mL Details

    Hemlibra 150 mg/mL

    Hemlibra is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Genentech, Inc.. The primary component is EMICIZUMAB.

    Product Information

    NDC 50242-0923
    Product ID 50242-923_bbf98231-9308-4099-9808-a170a48fdfb3
    Associated GPIs 85105030202040
    GCN Sequence Number 077937
    GCN Sequence Number Description emicizumab-kxwh VIAL 150 MG/ML SUBCUT
    HIC3 M0P
    HIC3 Description HEMOPHILIA TREATMENT AGENTS,NON-FACTOR REPLACEMENT
    GCN 44107
    HICL Sequence Number 044640
    HICL Sequence Number Description EMICIZUMAB-KXWH
    Brand/Generic Brand
    Proprietary Name Hemlibra
    Proprietary Name Suffix n/a
    Non-Proprietary Name emicizumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 150
    Active Ingredient Units mg/mL
    Substance Name EMICIZUMAB
    Labeler Name Genentech, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761083
    Listing Certified Through 2024-12-31

    Package

    NDC 50242-0923-01 (50242092301)

    NDC Package Code 50242-923-01
    Billing NDC 50242092301
    Package 1 VIAL, SINGLE-USE in 1 CARTON (50242-923-01) / 1 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2017-11-16
    NDC Exclude Flag N
    Pricing Information N/A